Reducing HSV-2 Transmission Without Condoms

Primary Transmission Reduction Strategy

• The Centers for Disease Control and Prevention recommends daily suppressive antiviral therapy with valacyclovir 500 mg once daily in the infected partner, which reduces transmission risk by approximately 48-50% and reduces symptomatic disease by 75% in susceptible heterosexual partners 1
• Daily suppressive antiviral therapy reduces asymptomatic viral shedding from 10.8% of days to 2.9% of days and decreases recurrence rates from 0.40 to 0.11 per month, according to the MMWR Recommendations and Reports 1

Behavioral Modifications

• The Centers for Disease Control and Prevention advises avoiding all sexual contact when visible genital or orolabial lesions are present, and recognizing prodromal symptoms that precede visible lesions to avoid contact during these periods as well 1, 2
• Sexual transmission occurs most commonly during asymptomatic periods when no lesions are visible, which is the primary mode of HSV-2 spread, as reported by the MMWR Recommendations and Reports 1, 2

Partner Communication and Testing

• Both partners must receive comprehensive counseling about the natural history of HSV-2, including the potential for asymptomatic transmission, as recommended by the MMWR Recommendations and Reports 1, 2
• HSV-2-seronegative partners should request type-specific serologic testing of new partners before initiating sexual activity, according to the MMWR Recommendations and Reports 1

Common Pitfalls to Avoid

• The MMWR Recommendations and Reports warns against assuming that episodic treatment reduces transmission risk, as only daily suppressive therapy has this effect 2
• The MMWR Recommendations and Reports advises against relying solely on avoiding sex during visible outbreaks, as the majority of transmission occurs during asymptomatic periods 1, 2

Special Considerations

• Women of childbearing age must inform obstetric providers about HSV-2 status during any pregnancy due to risk of neonatal infection, as recommended by the MMWR Recommendations and Reports 2

Genital Herpes Transmission and Prevention

Understanding Asymptomatic Transmission

• The Centers for Disease Control and Prevention (CDC) states that sexual transmission of HSV can occur during asymptomatic shedding, a critical concept for patient counseling 3
• Asymptomatic viral shedding occurs more frequently in patients with HSV-2 infection compared to HSV-1 genital infection, and in patients who have had genital herpes for less than 12 months 4

Risk Reduction Strategies

• The CDC recommends that partners avoid sexual contact when visible lesions are present, but understand that this alone does not eliminate transmission risk 3, 4
• Consistent latex condom use reduces HSV-2 acquisition from women to men and from men to women, according to the CDC 3
• Suppressive antiviral therapy with valacyclovir 500 mg once daily in the infected partner reduces HSV-2 transmission to susceptible heterosexual partners by 48-50%, as recommended by the CDC 3

Critical Counseling Points

• Transmission can occur even when using condoms and suppressive therapy, as stated by the CDC 3, 5

Reducing Transmission Risk of Genital Herpes

Understanding the Disease

• Only 13% of HSV-2 infected persons have been diagnosed, meaning most people don't know they have it, according to the Clinical Infectious Diseases 6, 7

Prevention Strategies

• The American College of Physicians and Infectious Diseases Society of America recommend daily suppressive valacyclovir 500 mg once daily for the infected partner, which reduces transmission risk by approximately 48-50%, and consistent condom use provides additional protection, though neither strategy eliminates transmission risk entirely, as noted by the Clinical Infectious Diseases 6, 7
• HSV-2 infection increases HIV acquisition risk 3-fold, as reported by the Clinical Infectious Diseases 7

Risk of Oral Herpes Transmission to Male Genitals Through Fellatio

Understanding the Transmission Risk

• The transmission of herpes simplex virus from oral lesions to genital sites through fellatio is a well-established route of infection, with HSV-1 becoming an increasingly common cause of first-episode genital herpes, particularly through oral-genital contact 8
• Oral HSV (both HSV-1 and HSV-2) can be transmitted to the penis during fellatio, with this route representing a significant and growing proportion of new genital herpes cases 8
• The virus requires access to mucosal surfaces or microabrasions in the epithelium to establish infection, which can occur during oral-genital contact 9

Risk Reduction Strategies

• Consistent use of condoms during fellatio reduces but does not eliminate HSV transmission risk, as condoms may not provide complete protection as they do not cover all potentially infected oral mucosal surfaces that contact genital skin 9

Critical Counseling Points

• Most persons with oral HSV infection are unaware they have it or do not recognize their symptoms, making unintentional transmission common 8
• Approximately 47.8% of the US population aged 14-49 years is seropositive for HSV-1, which can cause both oral and genital infection 8
• Genital herpes acquired through any route increases HIV acquisition risk 3-fold, making prevention of HSV transmission particularly important 8

Condom Use During Oral Sex and HSV Transmission Risk

Effectiveness of Condoms

• Consistent condom use during fellatio may lower the risk of herpes simplex virus (HSV) transmission, but existing studies are inconsistent and do not provide precise estimates of how much protection is achieved. 10, 11

HSV‑2 Transmission and Prevention Guidelines

Transmission Dynamics

• Asymptomatic viral shedding is frequent and is the primary mechanism by which HSV‑2 spreads between sexual partners, occurring even in the complete absence of visible lesions. This underscores that transmission can happen at any time, not only during outbreaks. 12
• The risk of transmission peaks during visible genital lesions or ulcers, when viral loads are markedly higher. Symptomatic outbreaks therefore represent periods of especially high infectivity. 12

Awareness and Public Health Impact

• Approximately 87 % of individuals infected with HSV‑2 are unaware of their infection, leading to inadvertent viral shedding and transmission during asymptomatic periods. This highlights the need for routine screening and education. 13

Impact on HIV Acquisition

• HSV‑2 infection increases the risk of acquiring HIV by roughly three‑fold, likely due to genital tract inflammation and enhanced viral entry points. Preventing HSV‑2 transmission is therefore critical in populations at risk for HIV. 13

Prevention Recommendations

• Avoiding all sexual contact when visible lesions or prodromal symptoms (e.g., tingling, burning, pain) are present is essential, although it does not eliminate transmission because most spread occurs during asymptomatic shedding. This recommendation should be emphasized in counseling. 12

HSV‑2 Transmission Dynamics (Cited Evidence)

Symptomatic Outbreak Transmission

• Vesicles formed during genital herpes outbreaks contain thousands of infectious HSV‑2 particles, providing a high‑risk window for direct sexual transmission when lesions are visible. 14

Primary Infection Characteristics

• The initial (primary) HSV‑2 infection in a previously seronegative individual is associated with the highest viral loads and the longest duration of viral shedding, making this period the most contagious phase of infection. 14
• The incubation period after exposure ranges from 2 – 10 days (up to 4 weeks in some cases), during which asymptomatic viral shedding can occur and transmission to partners is possible. 14

Recurrence Frequency and Transmission Opportunities

• Reactivation episodes vary widely among individuals, occurring from as infrequently as once every several years to as often as multiple times per month; each reactivation episode creates an additional opportunity for HSV‑2 transmission. 15